InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cardiff Oncology, Inc.

CRDF Clue Score55
United States Fiscal year ends December CIK 0001213037
$1.08 +1.89% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.08 −83.90% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.4Operating income−40.1Net income−39.2EPS, diluted−1.37Fiscal year 2017Revenue0.5 +32.6%Operating income−25.6Net income−24.9EPS, diluted−51.76Fiscal year 2018Revenue0.4 −25.1%Operating income−17.1Net income−16.5EPS, diluted−8.26Fiscal year 2019Revenue0.2 −35.3%Operating income−16.7Net income−16.4Fiscal year 2020Revenue0.4 +49.6%Operating income−19.1Net income−19.3EPS, diluted−1.08Fiscal year 2021Revenue0.4 −1.9%Operating income−28.9Net income−28.3EPS, diluted−0.73Fiscal year 2022Revenue0.4 +7.5%Operating income−39.9Net income−38.7EPS, diluted−0.89Fiscal year 2023Revenue0.5 +26.4%Operating income−45.4Net income−41.4EPS, diluted−0.93Fiscal year 2024Revenue0.7 +40.0%Operating income−48.7Net income−45.4EPS, diluted−0.95Fiscal year 2025Revenue0.6 −13.2%Operating income−49.0Net income−45.9EPS, diluted−0.69
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.5 0.7 0.6
Growth +32.6% −25.1% −35.3% +49.6% −1.9% +7.5% +26.4% +40.0% −13.2%
Operating income −40.1 −25.6 −17.1 −16.7 −19.1 −28.9 −39.9 −45.4 −48.7 −49.0
Net income −39.2 −24.9 −16.5 −16.4 −19.3 −28.3 −38.7 −41.4 −45.4 −45.9
Growth
EPS, diluted −1.37 −51.76 −8.26 n/a −1.08 −0.73 −0.89 −0.93 −0.95 −0.69

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin−10,534.9%Net margin−10,287.7%Free cash flow margin−8,361.5%Fiscal year 2017Operating margin−5,064.4%Net margin−4,928.1%Free cash flow margin−4,626.4%Fiscal year 2018Operating margin−4,507.6%Net margin−4,351.1%Free cash flow margin−3,490.2%Fiscal year 2019Operating margin−6,817.8%Net margin−6,709.7%Free cash flow margin−5,451.1%Fiscal year 2020Operating margin−5,214.8%Net margin−5,275.1%Free cash flow margin−4,515.3%Fiscal year 2021Operating margin−8,037.6%Net margin−7,880.5%Free cash flow margin−6,474.9%Fiscal year 2022Operating margin−10,337.3%Net margin−10,026.9%Free cash flow margin−9,022.3%Fiscal year 2023Operating margin−9,305.7%Net margin−8,492.0%Free cash flow margin−6,448.6%Fiscal year 2024Operating margin−7,123.1%Net margin−6,651.7%Free cash flow margin−5,530.5%Fiscal year 2025Operating margin−8,256.3%Net margin−7,732.0%Free cash flow margin−6,402.5%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −10,534.9% −5,064.4% −4,507.6% −6,817.8% −5,214.8% −8,037.6% −10,337.3% −9,305.7% −7,123.1% −8,256.3%
Net margin −10,287.7% −4,928.1% −4,351.1% −6,709.7% −5,275.1% −7,880.5% −10,026.9% −8,492.0% −6,651.7% −7,732.0%
Free cash flow margin −8,361.5% −4,626.4% −3,490.2% −5,451.1% −4,515.3% −6,474.9% −9,022.3% −6,448.6% −5,530.5% −6,402.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−31.0Capital expenditure−0.8Free cash flow−31.9Fiscal year 2017Operating cash flow−23.3Capital expenditure−0.1Free cash flow−23.4Fiscal year 2018Operating cash flow−13.2Capital expenditure−0.0Free cash flow−13.2Fiscal year 2019Operating cash flow−13.3Capital expenditure−0.1Free cash flow−13.3Fiscal year 2020Operating cash flow−16.3Capital expenditure−0.2Free cash flow−16.5Fiscal year 2021Operating cash flow−23.0Capital expenditure−0.2Free cash flow−23.2Fiscal year 2022Operating cash flow−33.8Capital expenditure−1.0Free cash flow−34.8Fiscal year 2023Operating cash flow−30.9Capital expenditure−0.6Free cash flow−31.5Fiscal year 2024Operating cash flow−37.7Capital expenditure−0.1Free cash flow−37.8Fiscal year 2025Operating cash flow−37.9Capital expenditure−0.0Free cash flow−38.0
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −31.0 −23.3 −13.2 −13.3 −16.3 −23.0 −33.8 −30.9 −37.7 −37.9
Capital expenditure −0.8 −0.1 −0.0 −0.1 −0.2 −0.2 −1.0 −0.6 −0.1 −0.0
Free cash flow −31.9 −23.4 −13.2 −13.3 −16.5 −23.2 −34.8 −31.5 −37.8 −38.0
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash13.9Shareholders’ equity19.8Fiscal year 2017Cash8.2Shareholders’ equity6.5Fiscal year 2018Cash11.5Shareholders’ equity10.1Fiscal year 2019Cash10.2Shareholders’ equity7.3Fiscal year 2020Cash131.0Shareholders’ equity128.2Fiscal year 2021Cash11.9Shareholders’ equity140.4Fiscal year 2022Cash16.3Shareholders’ equity106.3Fiscal year 2023Cash21.7Shareholders’ equity69.7Fiscal year 2024Cash51.5Shareholders’ equity82.9Fiscal year 2025Cash17.5Shareholders’ equity45.4
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 13.9 8.2 11.5 10.2 131.0 11.9 16.3 21.7 51.5 17.5
Shareholders’ equity 19.8 6.5 10.1 7.3 128.2 140.4 106.3 69.7 82.9 45.4

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017† 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
0.4 0.5 0.4 0.2 0.4 0.4 0.4 0.5 0.7 0.6
Growth +32.6% −25.1% −35.3% +49.6% −1.9% +7.5% +26.4% +40.0% −13.2%
1.7 1.8 0.6 0.0 n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a 11.2 17.4 27.1 n/a n/a n/a
11.5 14.2 8.0 5.8 8.2 11.8 13.2 13.0 12.5 14.2
−40.1 −25.6 −17.1 −16.7 −19.1 −28.9 −39.9 −45.4 −48.7 −49.0
Growth
n/a n/a n/a n/a n/a n/a n/a n/a −45.4 −45.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−39.2 −24.9 −16.5 −16.4 −19.3 −28.3 −38.7 −41.4 −45.4 −45.9
Growth
Per share
−1.30 −51.76 −8.26 n/a −1.08 −0.73 −0.89 −0.93 −0.95 −0.69
−1.37 −51.76 −8.26 n/a −1.08 −0.73 −0.89 −0.93 −0.95 −0.69
Growth
30.2 0.5 2.3 6.0 20.9 39.0 43.6 44.7 47.7 66.8
30.3 0.5 2.3 n/a 20.9 39.0 43.6 44.7 47.7 66.8
Growth −98.4% +383.8% +87.0% +11.7% +2.5% +6.7% +40.3%

† The diluted share count jumps at 2017 and 2018 and 2020 and 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 10.1% a year over five years.
  • Operating margin is down 3,041.6 points on five years ago, at -8,256.3%.
  • A net loss in 10 of 10 years on file.